Antibodies that could help develop a vaccine for HIV

George Georgiou, a professor of engineering and molecular biosciences at the University of Texas at Austin, and his colleagues have developed a hybrid antibody that neutralized 99 percent of HIV-1 strains tested. The antibody is based on so-called “broadly-neutralizing antibodies,” a group of antibodies from HIV-infected patients that are able to take down an array of rapidly mutating HIV-1 viruses.

The research was published last week in the journal Science Immunology.

Leave a Reply

Your email address will not be published. Required fields are marked *